I
Power Law company profile
Intracellular Therapies
Biotech & Life Sciences · New York City, United States · Founded 2002 · IPO 2014 Unicorn
Valuation
$377M
Market cap · Mar/2026
Revenue
$18M
Latest reported FY
Investors
2 investors on Intracellular Therapies's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Series A
1 investor entered at this stage
Series B+
1 investor entered at this stage
Global footprint
Where Intracellular Therapies has talent and traffic
Workforce by country
2
countries with
team presence
team presence
🇺🇸 United States99.6%
🇨🇦 Canada0.1%
Web traffic by country
15K
monthly visits
across markets
across markets
🇺🇸 United States92%
🇮🇳 India6%
🇬🇧 United Kingdom4%
Market sentiment
What the market is saying about Intracellular Therapies
An AI-synthesized read of the highest-engagement posts about Intracellular Therapies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Intracellular Therapies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.